TLDR
- MRAM hit a new 52-week high of $23.10 on May 8, last trading around $22.59 on volume of ~437,000
- Everspin signed a 10-year manufacturing deal with Microchip Technology to expand U.S.-based MRAM production at an Oregon fab
- Q1 EPS came in at $0.11 with revenue of $14.87M, beating the $14.60M estimate
- Q2 2026 EPS guidance is soft at $0.000–$0.030; analyst consensus is Hold with an average target of $18.50
- CEO and CFO sold a combined ~$796K worth of stock in early May
Everspin Technologies (MRAM) stock climbed to a new 52-week high of $23.10 on Friday, May 8, before settling around $22.59. That’s well above its 50-day moving average of $11.18 and 200-day moving average of $10.63.
Everspin Technologies, Inc., MRAM
Volume on the day hit roughly 437,000, up from the prior close of $21.51.
The stock has gained about 25% recently, driven largely by news of a manufacturing partnership announced in April.
The Microchip Deal
On April 8, Everspin announced a 10-year agreement with Microchip Technology to produce MRAM and Tunnel Magnetoresistive (TMR) sensor products at Microchip’s Oregon fabrication facility.
The deal keeps Everspin’s intellectual property and process ownership intact. It also adds ITAR-capable wafer processing, which matters for defense and aerospace customers.
Everspin will continue running its existing Chandler, Arizona fab in parallel. First products from the Oregon line are expected to ship in the second half of 2027.
The agreement can be extended in two-year increments beyond the initial 10-year term.
Earnings Were Fine, But Guidance Is Soft
Everspin posted Q1 2026 EPS of $0.11 and revenue of $14.87 million, clearing analyst expectations of $14.60 million.
Net margin was 0.50% and return on equity came in at 4.78%.
Q2 2026 guidance is a different story. The company guided for EPS of $0.000 to $0.030 — a wide and low range that signals near-term caution.
The market cap currently sits at $593 million, with a PE ratio of 2,532 — reflecting how early-stage the profitability story still is.
Analysts and Insiders Aren’t All Convinced
Wall Street is split. Needham raised its price target from $14.00 to $18.50 and maintained a Buy rating on April 30. Weiss Ratings kept a Sell rating in March. Wall Street Zen downgraded from Buy to Hold in February.
The consensus sits at Hold with an average target of $18.50 — well below where the stock is trading now.
On the insider side, CEO Sanjeev Aggarwal sold 28,459 shares at $19.58 on May 4, netting about $557,000. That reduced his stake by 3.36%.
CFO William Earl Cooper sold 11,000 shares at $21.75 on May 6, totaling $239,250 — a 6.39% reduction in his position.
In total, insiders sold roughly 60,448 shares worth about $990,000 over the past three months.
Institutional ownership stands at 44.68%, with several hedge funds initiating new positions in recent quarters, including Raymond James Financial, Kestra Advisory Services, and Occudo Quantitative Strategies.
The stock’s beta of 1.75 reflects a higher-volatility profile compared to the broader market.
🚨 Our MAY Stock Picks Are Live!
A new month means new opportunities. Our analysts have just released their top stock picks for May, highlighting companies with strong momentum that rank highly on our KO Score algorithm. We’re also now sharing trade ideas for both long-term and short-term investors, giving you more ways to spot potential opportunities in the market.
Sign up to Knockout Stocks today and get 50% off to unlock the full list and see which stocks made the cut.
Use coupon code Special50 for your exclusive discount!
